{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05305911",
            "orgStudyIdInfo": {
                "id": "1852152"
            },
            "organization": {
                "fullName": "Minneapolis Heart Institute Foundation",
                "class": "OTHER"
            },
            "briefTitle": "Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI",
            "officialTitle": "Sodium Glucose Co-Transporter 2 (SGLT2) Inhibition Improves Left Ventricular Function and Reduces Adverse Left-Ventricular Remodeling in High-Risk Patients With Microvascular Obstruction (MVO) Following ST-elevation Myocardial Infarction (STEMI).",
            "therapeuticArea": [
                "Cardiovascular"
            ],
            "study": "sodium-glucose-co-transporter-and-stemi"
        },
        "statusModule": {
            "statusVerifiedDate": "2022-08",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-08-03",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-04-15",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-04-15",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-03-14",
            "studyFirstSubmitQcDate": "2022-03-23",
            "studyFirstPostDateStruct": {
                "date": "2022-03-31",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2022-08-04",
            "lastUpdatePostDateStruct": {
                "date": "2022-08-05",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Minneapolis Heart Institute Foundation",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "The purpose of the research is to determine whether a medication called dapagliflozin will improve the heart's function and reduce its enlargement after a heart attack. Participation in this study will involve taking the medication dapagliflozin (or a placebo) once daily for six months, one cardiac magnetic resonance imaging (MRI) test during your initial hospitalization, follow-up phone calls at 1 and 3 months, and one cardiac MRI and clinic visit at six months."
        },
        "conditionsModule": {
            "conditions": [
                "Heart Attack",
                "Enlarged Heart"
            ],
            "keywords": [
                "Dapagliflozin",
                "Sodium Glucose Co-Transporter 2"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "maskingDescription": "Treatment will be blinded to the participant and study team. Assignment of treatment arm will be managed by Abbott Northwestern Heart Hospital pharmacy",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 80,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Treatment Group",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Treatment group will receive dapagliflozin in addition to standard heart attack medications for the duration of hospitalization and 6-month duration of the study.",
                    "interventionNames": [
                        "Drug: Dapagliflozin"
                    ]
                },
                {
                    "label": "Placebo Group",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Placebo Group will receive placebo in addition to standard heart attack medications for the duration of hospitalization and 6-month duration of the study.",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Dapagliflozin",
                    "description": "Dapagliflozin once daily for six months",
                    "armGroupLabels": [
                        "Treatment Group"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Placebo once daily for six months",
                    "armGroupLabels": [
                        "Placebo Group"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in LVESVI",
                    "description": "Change in LVESVI at 6 months as measured by MRI.",
                    "timeFrame": "6 Months"
                },
                {
                    "measure": "Change in LVEDVI",
                    "description": "Change in LVEDVI at 6 months as measured by MRI.",
                    "timeFrame": "6 Months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change in LV mass",
                    "description": "Change in LV mass at 6 months as measured by cMRI",
                    "timeFrame": "6 months"
                },
                {
                    "measure": "Change in LVEF",
                    "description": "Change in LVEF at 6 months as measured by cMRI",
                    "timeFrame": "6 months"
                },
                {
                    "measure": "MACE rates - including hospitalization for CHF, repeat revascularization, MI and death and ICD implantation",
                    "timeFrame": "1 year"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients with their first STEMI (\\> 18 years and \\< 75 years) who underwent successful primary PCI and able to give informed consent\n* At least mild LV dysfunction (LVEF \\< 50%) on echocardiogram, cMRI or Left Ventriculargram following PCI\n* Infarct size that is \\> 10% of LV mass\n* The presence of MVO that is \\> 10% of infarct size\n\nExclusion Criteria:\n\n* Contraindication to cardiac MRI\n* Life expectancy \\< 1 year\n* Previous CABG or Valve Surgery\n* Previous STEMI\n* Pregnant or planning to become pregnant or lactating women\n* Cardiogenic shock (not resolved)\n* Atrial fibrillation or recurrent sustained ventricular arrhythmias (excluding PVCs)\n* GFR\\<30 ml/min/1.73m2 or end-stage renal disease on dialysis\n* Type 1 diabetes mellitus or history of diabetic ketoacidosis\n* Type I or II diabetes with insulin use\n* Prior intolerance of SGLT2 inhibitors\n* Current use of SGLT2 inhibitors\n* Contraindications to gadolinium",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "75 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Sarah Schwager, RN",
                    "role": "CONTACT",
                    "phone": "612-863-3833",
                    "email": "sarah.schwager@allina.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Jay Traverse, MD",
                    "affiliation": "Minneapolis Heart Institute Foundation",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Minneapolis Heart Institute Foundation",
                    "status": "RECRUITING",
                    "city": "Minneapolis",
                    "state": "Minnesota",
                    "zip": "55407",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Sarah Schwager, RN",
                            "role": "CONTACT",
                            "phone": "612-863-3833",
                            "email": "sarah.schwager@allina.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.97997,
                        "lon": -93.26384
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009203",
                    "term": "Myocardial Infarction"
                },
                {
                    "id": "D000006332",
                    "term": "Cardiomegaly"
                }
            ],
            "ancestors": [
                {
                    "id": "D000017202",
                    "term": "Myocardial Ischemia"
                },
                {
                    "id": "D000006331",
                    "term": "Heart Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                },
                {
                    "id": "D000014652",
                    "term": "Vascular Diseases"
                },
                {
                    "id": "D000007238",
                    "term": "Infarction"
                },
                {
                    "id": "D000007511",
                    "term": "Ischemia"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000009336",
                    "term": "Necrosis"
                },
                {
                    "id": "D000006984",
                    "term": "Hypertrophy"
                },
                {
                    "id": "D000020763",
                    "term": "Pathological Conditions, Anatomical"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12155",
                    "name": "Myocardial Infarction",
                    "asFound": "Heart Attack",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10282",
                    "name": "Infarction",
                    "relevance": "LOW"
                },
                {
                    "id": "M1072",
                    "name": "ST Elevation Myocardial Infarction",
                    "relevance": "LOW"
                },
                {
                    "id": "M22079",
                    "name": "Ventricular Remodeling",
                    "relevance": "LOW"
                },
                {
                    "id": "M9420",
                    "name": "Cardiomegaly",
                    "asFound": "Enlarged Heart",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6546",
                    "name": "Coronary Artery Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "M19506",
                    "name": "Myocardial Ischemia",
                    "relevance": "LOW"
                },
                {
                    "id": "M10543",
                    "name": "Ischemia",
                    "relevance": "LOW"
                },
                {
                    "id": "M9419",
                    "name": "Heart Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17400",
                    "name": "Vascular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12284",
                    "name": "Necrosis",
                    "relevance": "LOW"
                },
                {
                    "id": "M10035",
                    "name": "Hypertrophy",
                    "relevance": "LOW"
                },
                {
                    "id": "M22519",
                    "name": "Pathological Conditions, Anatomical",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000529054",
                    "term": "Dapagliflozin"
                }
            ],
            "ancestors": [
                {
                    "id": "D000077203",
                    "term": "Sodium-Glucose Transporter 2 Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000007004",
                    "term": "Hypoglycemic Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M348449",
                    "name": "Dapagliflozin",
                    "asFound": "10 minutes",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1691",
                    "name": "Sodium-Glucose Transporter 2 Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M10054",
                    "name": "Hypoglycemic Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Hypo",
                    "name": "Hypoglycemic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}